Kirkland Signature Glucosamine Sulfate
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de pottasium provenant d¿exosquelettes de crabes | 750 mg | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de pottasium provenant d¿exosquelettes de crevettes | 750 mg | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Aspergillus niger - En entier | 750 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropyl méthylcellulose, Cellulose microcristalline, Stéarate de magnésium, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps to relieve joint pain associated with osteoarthritis (of the knee). Helps to protect against the deterioration of cartilage. A factor in maintaining healthy cartilage and/or joint health. Helps protect against the deterioration of cartilage and relieve joint pain associated with osteoarthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Other names
- GLS, GLS 750 mg, Glucosamine Sulfate, Glucosamine Sulfate 750 mg, Kirkland Signature GLS, Kirkland Signature GLS 750 mg, Kirkland Signature Glucosamine Sulfate 750 mg
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80097421
- Status
- Active licence
- Licence date
- 5 March 2020
- Revision date
- 12 February 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80097421
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Kirkland Signature Glucosamine Sulfate (WN Pharmaceuticals Ltd): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80097421-kirkland-signature-glucosamine-sulfate, updated 12 February 2024.